Christopher L Cubitt

7PUBLICATIONS
68CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 20, 2026
Expanded antigen-specific donor regulatory T cells for GVHD prevention.

|Jun 03, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.

|May 25, 2026
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.

|May 05, 2025
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma.

Rafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads

|Oct 30, 2024
The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma.

Praneeth Reddy Sudalagunta, Rafael R Canevarolo, Mark B Meads

|Jan 22, 2024
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients.

Christopher W Dukes, Marine Potez, Jeffrey Lancet

Pageof 2

Frequent Collaborators

3 joint publications

Rafael Renatino Canevarolo

3 joint publications

Robert A Gatenby

3 joint publications

Ariosto Siqueira Silva

3 joint publications

Jamie K Teer